NASDAQ:ALPS 1 November 2025 - 3 November 2025

ALPS Group Inc. closed its Nasdaq debut at $2.56 per share on Oct. 31, 2025, after a SPAC merger, then plunged about 34% to $1.69 in pre-market trading Nov. 3. The Malaysian biotech’s public float was limited to roughly 3.5 million shares, fueling sharp volatility. Most shares remain locked up with insiders. The company raised $3.1 million in a concurrent PIPE.

Alps Group Inc (ALPS) began trading on Nasdaq Oct 31, 2025, opening near $2.55 and closing at $2.56 after a SPAC merger that valued the company at $1.6 billion. First-day volume reached about 590,000 shares, with a market cap near $10–12 million. ALPS, led by CEO Dr. Tham Seng Kong, raised $3.1 million in PIPE financing. The company reported no revenue and a net loss of $2 million pre-merger.